Involvement of receptor tyrosine phosphatase DEP-1 mediated PI3K-cofilin signaling pathway in Sorafenib-induced cytoskeletal rearrangement in hepatoma cells

Journal of Cellular Physiology

Volumn 224, Issue 2, 2010, Pages 559-565

  Wang, Ziqiu ^a   Wang, Meifang ^a   Carr, Brian I ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COFILIN; F ACTIN; G ACTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; RECEPTOR TYROSINE PHOSPHATASE DENSITY ENHANCED PHOSPHATASE 1; SORAFENIB; TYROSINE; UNCLASSIFIED DRUG; WORTMANNIN; ACTIN; BENZENESULFONIC ACID DERIVATIVE; COFILIN 1; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOTYROSINE; PYRIDINE DERIVATIVE; SCATTER FACTOR RECEPTOR; SSH1 PROTEIN, HUMAN;

ACTIN POLYMERIZATION; ARTICLE; CANCER GROWTH; CELL SHAPE; CYTOSKELETON; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; BIOLOGICAL MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; BENZENESULFONATES; CARCINOMA, HEPATOCELLULAR; COFILIN 1; CYTOSKELETON; ENZYME ACTIVATION; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTO-ONCOGENE PROTEINS C-MET; PYRIDINES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; SIGNAL TRANSDUCTION;

EID: 77953635841     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22160     Document Type: Article

References (30)

1. Andrianantoandro E, Pollard TD. 2006. Mechanism of actin filament turnover by severing and nucleation at different concentrations of ADF/cofilin. Mol Cell 24:13-23.
2. Bailly M, Jones GE. 2003. Polarised migration: Cofilin holds the front. Curr Biol 13:128-130.
3. Bamburg JR. 1999. Proteins of the ADF/cofilin family: Essential regulators of actin dynamics. Annu Rev Cell Dev Biol 15:185-230.
4. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. 1991. Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science 251:802-804. (Pubitemid 21926175)
5. Carlomagno F, Anaganti S, Guida T, Salvatore G, Troncone G, Wilhelm SM, Santoro M. 2006. Bay 43-9006 inhibition of oncogenic RET mutants. J Natl Cancer Inst 98:326-334. (Pubitemid 43338212)
6. Chung CY, Funamoto S, Firtel RA. 2002. Signaling pathways controlling cell polarity and chemotaxis. Trends Biochem Sci 26:557-566.
7. dos Remedios CG, Chhabra D, Kekic M, Dedova IV, Tsubakihara M, Berry DA, Nosworthy NJ. 2003. Actin binding proteins: Regulation of cytoskeletal microfilaments. Physiol Rev 83:433-473.
8. Hotulainen P, Paunola E, Vartiainen MK, Lappalainen P. 2005. Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells. Mol Biol Cell 16:649-664. (Pubitemid 40165562)
9. Huang TY, DerMardirossian C, Bokoch GM. 2005. Cofilin phosphatases and regulation of actin dynamics. Curr Opin Cell Biol 18:26-31.
10. Keane M, Lowrey G, Ettenberg S, Dayton M, Lipkowitz S. 1996. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res 56:4236-4243. (Pubitemid 26305022)
11. Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C. 2006. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 66:11851-11858. (Pubitemid 46094197)
12. Mitchison TJ, Cramer LP. 1996. Actin-based cell motility and cell locomotion. Cell 84:371-379.
13. Mouneimne G, Soon L, DesMarais V, Sidani M, Song X, Yip SC, Ghosh M, Eddy R, Backer JM, Condeelis J. 2004. Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation. J Cell Biol 166:697-708. (Pubitemid 39181007)
14. Mouneimne G, DesMarais V, Sidani M, Scemes E, Wang W, Song X, Eddy R, Condeelis J. 2006. Spatial and temporal control of cofilin activity is required for directional sensing during chemotaxis. Curr Biol 16:2193-2205. (Pubitemid 44739276)
15. Naldini L, Vigna E, Ferracini R, Longati P, Gandino L, Prat M, Comoqlio PM. 1991. The tyrosine kinase encoded by the MET proto-oncogene is activated by auto-phosphorylation. Mol Cell Biol 11:1793-1803. (Pubitemid 21895545)
16. Nishita M, Wang Y, Tomizawa C, Suzuki A, Niwa R, Uemura T, Mizuno K. 2004. Phosphoinositide 3-kinase-mediated activation of cofilin phosphatase Slingshot and its role for insulin-induced membrane protrusion. J Biol Chem 279:7193-7198. (Pubitemid 38248866)
17. Niwa R, Nagata-Ohashi K, Takeichi M, Mizuno K, Uemura T. 2002. Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin. Cell 108:233-246. (Pubitemid 34161143)
18. Palka HL, Park M, Tonks NK. 2003. Hepatocyte growth factor receptor tyrosine kinase Met is a substrat of the receptor protein-tyrosine phosphatase DEP-1. J Biol Chem 278:5728-5735. (Pubitemid 36800817)
19. Pollard TD, Borusy GG. 2003. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112:453-465.
20. Rahmani M, Davis EM, Bauer C, Dent P, Grant S. 2005. Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. J Biol Chem 280:35217-35227. (Pubitemid 41532709)
21. Rickert P, Weiner OD, Wang F, Bourne HR, Servant G. 2000. Leukocytes navigate by compass: Roles of PI3Kgamma and its lipid products. Trends Cell Biol 10:466-473.
22. Rosenblatt J, Mitchison TJ. 1998. Actin, cofilin and cognition. Nature 393:739-740.
23. Saltiel AR, Pessin JE. 2002. Insulin signaling pathways in time and space. Trends Cell Biol 12:65-71.
24. Toshima J, Toshima JY, Amano T, Yang N, Narumiya S, Mizuno K. 2001. Cofilin phosphorylation by protein kinase testicular protein kinase 1 and its role in integrin-mediated actin reorganization and focal adhesion formation. Mol Biol Cell 12:1131-1145. (Pubitemid 33052004)
25. Wang W, Eddy R, Condeelis J. 2007. The cofilin pathway in breast cancer invasion and metastasis. Nature Rev 7:429-440. (Pubitemid 46809168)
26. Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, Cao Y, Shujath J, Gawlak S, Eveleigh D, Rowley B, Liu L, Adnane L, Lynch M, Auclair D, Taylor I, Gedrich R, Voznesensky A, Riedl B, Post LE, Bollag G, Trail PA. 2004. Bay 43-9006 exhibits broad spectrum oral antitumor activity and targets the Raf/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 64: 7099-7109.
27. Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. 2008. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther 7:3129-3140.
28. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida E, Mizuno K. 1998. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393:809-812.
29. Yu C, Bruzek LM, Meng XW, Gores GJ, Carter CA, Kaufmann SH, Adjei AA. 2005. The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006. Oncogene 24:6861-6869.
30. Zhu H, Naujokas MA, Fixman ED, Torossian K, Park M. 1994. Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis. J Biol Chem 269:29943-29948.